Epidemiology, Etiology, and Natural History of Colorectal Liver Metastases

Malignant Liver Tumors: Current and Emerging Therapies: Third Edition

Volumn , Issue , 2009, Pages 64-68

  Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Colorectal cancer, common malignancies in Western countries; Epidemiology, etiology, and natural history of colorectal liver metastases; Identifying adverse prognostic factors precluding surgical resection; Liver metastasis detection; Metachronous liver metastases or metastases; Studies focusing on genetic expression profile of patients with colorectal liver metastases; Synchronous metastasis

Indexed keywords

EID: 84873667621     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444317053.ch7     Document Type: Chapter

References (28)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Canacer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. Benson AP. Epidemiology, disease progression and economic burden of colorectal cancer. J Manag Care Pharm 2007; 13 (Suppl S-c): S5-S18.
3. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol 2007; 16: 3-5.
4. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Gig Dis 2007; 8: 179-85.
5. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006; 101: 2128-38.
6. Fong Y, Kemeny N, Paty P, Blumgart LH, Cohen AM. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol 1996; 12: 219-52.
7. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg 1999; 230: 309-21.
8. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244: 254-9.
9. Gatta G, Capocaccia R, Sant M, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000; 47: 533-8.
10. Kune GA, Kune S, Field B, White R, Brough W, Schellenberger R, Watson LF. Survival in patients with large-bowel cancer: a population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 1990; 33: 938-46.
11. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-8.
12. Uen YH, Lin SR, Wu DC, et al. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann Surg 2007; 246: 1040-6.
13. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy:a model to predict long-term survival. Ann Surg 2004; 240: 644-57.
14. Clavien PA, Petrowsky H, deOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-59.
15. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976; 2: 285-8.
16. Nortstein J, Silen W. Natural history of liver metastases from colorectal carcinoma. J Gastrointest Surg 1997; 1: 398-407.
17. Finan PJ, Marshall RJ, Cooper EH, Giles GR. Factors affecting survival in patients presenting with synchronous hepatic metastasis from colorectal cancer: a clinical and computer analysis. Br J Surg 1985; 72: 373-7.
18. Finlay IG, Meek D, Brunton F, McArdle CS. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg 1988; 75: 641-4.
19. Purkiss SF, Williams NS. Growth rate and percentage hepatic replacement of colorectal liver metastases. Br J Surg 1993; 80: 1036-8.
20. Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-7.
21. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405-10.
22. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-8.
23. Minagawa M, Yamamoto J, Kosuge T, Matsuyama Y, Miyagawa S, Makuuchi M. Simplified staging system for predicting the prognosis of patients with resectable liver metastasis. Arch Surg 2007; 142: 269-76.
24. Diep CB, Teixeira MR, Thorstensen L, et al. Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients. Mol Cancer 2004; 3: 6.
25. Yamasaki M, Takemasa I, Komori T, et al. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 2007; 30: 129-38.
26. Ki DH, Jeung HC, Park CH, et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 2007; 121: 2005-12.
27. Hafstrom L, Engaras B, Holmberg SB, et al. Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial. Cancer 1994; 74: 2749-56.
28. Gorog D, Toth A, Weltner J. Prognosis of untreated liver metastasis from colorectal cancer. Acta Chir Hung 1997; 36: 106-7.